| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| 08/27/2026 | ±2.9% | +22.6% | under-priced |
| 05/28/2026 | ±3.8% | -0.8% | over-priced |
| 03/02/2026 | ±5.4% | -0.9% | over-priced |
| 12/04/2025 | ±2.5% | +3.7% | under-priced |
| 09/04/2025 | ±2.5% | -4.8% | under-priced |
| 05/29/2025 | ±2.7% | -3.3% | under-priced |
| 03/05/2025 | ±3.8% | +1.6% | over-priced |
| 12/04/2024 | ±2.3% | +11.0% | under-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q2 FY2027 | $4.29 | $11.3B | $3.5B |
| Q1 FY2027 | $2.42 | $11.1B | $2.1B |
| Q4 FY2025 | — | $13.6B | $3.0B |
| Q3 FY2026 | $2.19 | $10.3B | $2.1B |
Salesforce, Inc. (CRM) reports in 27 days, with the next report estimated for 11/24/2026. Across the last 8 reports, options priced an average ±3.2% earnings move while the stock actually moved 6.1% on average — the market has been roughly fair on CRM's earnings risk. Fundamentals into the print: EPS up 118.9% year-over-year, revenue up 10.8%. QuantLogix's live 5-factor engine currently reads CRM as a buy at 73/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →